# A Study of Avastin (Bevacizumab) in Combination With Standard Chemotherapy in Children and Adolescents With Sarcoma.

> **NCT00643565** · PHASE2 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 154 (actual)

## Conditions studied

- Sarcoma

## Interventions

- **DRUG:** Standard chemotherapy
- **DRUG:** bevacizumab [Avastin]

## Key facts

- **NCT ID:** NCT00643565
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-07-29
- **Primary completion:** 2015-05-31
- **Final completion:** 2019-04-30
- **Target enrollment:** 154 (ACTUAL)
- **Last updated:** 2019-10-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00643565

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00643565, "A Study of Avastin (Bevacizumab) in Combination With Standard Chemotherapy in Children and Adolescents With Sarcoma.". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT00643565. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*